Stockholder's Equity and Employee Benefit Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
Sep. 30, 2022	Dec. 31, 2021
Number of Shares
Outstanding at December 31, 2021	14,527,520
Granted	940,000
Exercised	(206,132)
Forfeited	(597,459)
Expired	(797,944)
Outstanding, vested and expected to vest at September 30, 2022	13,865,985	14,527,520
Vested and exercisable at September 30, 2022	11,152,332
Weighted Average Exercise Price
Outstanding at December 31, 2021	$ 17.11
Granted	7.14
Exercised	13.71
Forfeited	20.09
Expired	18.31
Outstanding, vested and expected to vest at September 30, 2022	16.29	$ 17.11
Vested and exercisable at September 30, 2022	$ 16.39
Outstanding at December 31, 2021	$ 61,227
Outstanding, vested and expected to vest, Aggregate Intrinsic Value, at September 30, 2022	2	$ 61,227
Vested and exercisable at September 30, 2022	$ 2
Outstanding, vested and expected to vest, Weighted Average Remaining Contractual Term	4 years 10 months 24 days	6 years 3 months 18 days
Vested and exercisable, Weighted Average Remaining Contractual Term	4 years 8 months 12 days

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.